Paratek Pharmaceuticals (PRTK) News Today → The #1 Crypto for AI (From Weiss Ratings) (Ad) Free PRTK Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineParatek Reports Positive Data For Nuzyra As Post-exposure Prophylaxis Of Pulmonary Anthrax In NHPsmarkets.businessinsider.com - March 5 at 9:02 AMMira Pharmaceuticals Stock (NASDAQ:MIRA) Dividends: History, Yield and Datesbenzinga.com - February 24 at 7:12 AMParatek Pharmaceuticals to Present NUZYRA Data at IDWeek 2023finance.yahoo.com - October 5 at 10:32 AMNovo Holdings closes $462 mln acquisition of Paratek Pharmaceuticalsfinance.yahoo.com - September 21 at 3:10 PMGurnet Point Capital and Novo Holdings A/S Complete Acquisition of Paratek Pharmaceuticals, Inc.finance.yahoo.com - September 21 at 9:18 AMmarketbeat.com - September 21 at 6:03 AMParatek Pharmaceuticals, Inc. (NASDAQ:PRTK) is definitely on the radar of institutional investors who own 48% of the companyfinance.yahoo.com - September 19 at 2:28 PMParatek Pharmaceuticals shareholders approve $462M buyout dealbizjournals.com - September 18 at 2:04 PMParatek Pharmaceuticals Announces Stockholder Approval of Acquisition by Gurnet Point Capital and Novo Holdings A/Sfinance.yahoo.com - September 18 at 2:04 PMSecond Leading Independent Proxy Advisory Firm Glass Lewis Recommends Paratek Pharmaceuticals Stockholders Vote FOR the Acquisition by Gurnet Point Capital and Novo Holdings A/Sfinance.yahoo.com - September 12 at 10:39 AMLeading Independent Proxy Advisory Firm ISS Recommends Paratek Pharmaceuticals Stockholders Vote FOR the Acquisition by Gurnet Point Capital and Novo Holdingsfinance.yahoo.com - September 7 at 6:13 PMAcadian Asset Management LLC Sells 107,287 Shares of Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK)marketbeat.com - September 7 at 5:23 AMSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TRTN, AMED, PRTKbenzinga.com - August 10 at 3:43 AMHC Wainwright Comments on Paratek Pharmaceuticals, Inc.'s Q3 2023 Earnings (NASDAQ:PRTK)marketbeat.com - August 9 at 8:18 AMH.C. Wainwright Keeps Their Hold Rating on Paratek Pharmaceuticals (PRTK)markets.businessinsider.com - August 7 at 9:42 AMNews Flash: Analysts Just Made A Captivating Upgrade To Their Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Forecastsfinance.yahoo.com - August 4 at 3:58 PMCarlyle Group Inc. Takes Position in Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK)marketbeat.com - August 4 at 1:53 PMParatek Pharmaceuticals Files Definitive Proxy Statement and Letter to Stockholders in Connection with Acquisition by Gurnet Point Capital and Novo Holdingsfinance.yahoo.com - August 3 at 10:50 AMParatek Pharmaceuticals Announces Second Quarter 2023 Revenue of $40.0 Millionfinance.yahoo.com - August 3 at 10:50 AMPRTK Paratek Pharmaceuticals, Inc.seekingalpha.com - July 27 at 5:19 AMNexPoint Sends Demand Letter for Books and Records to Paratek Pharmaceuticals in Connection with Proposed Acquisition by Gurnet Point Capitalfinance.yahoo.com - July 11 at 8:40 PMHC Wainwright & Co. Reiterates Paratek Pharmaceuticals (PRTK) Neutral Recommendationmsn.com - July 11 at 10:35 AMH.C. Wainwright Reaffirms Their Hold Rating on Paratek Pharmaceuticals (PRTK)markets.businessinsider.com - July 10 at 1:02 PMParatek Pharmaceuticals Announces Modification of BARDA Contract to Advance the Development of NUZYRA® (omadacycline) for Post-Exposure Prophylaxis (PEP) and Treatment of Pulmonary Anthraxfinance.yahoo.com - July 10 at 1:02 PMParatek Pharmaceuticals (PRTK) Price Target Decreased by 41.87% to 3.16msn.com - July 6 at 11:44 PMParatek Pharmaceuticals (NASDAQ:PRTK) Earns Hold Rating from Analysts at StockNews.commarketbeat.com - June 30 at 1:25 AMParatek antibiotic Nuzyra to receive EU orphan drug statusmsn.com - June 27 at 3:31 PMParatek investor NexPoint warns it may vote against takeover dealmsn.com - June 27 at 3:31 PMParatek Pharmaceuticals Acknowledges Receipt of NexPoint Letterfinance.yahoo.com - June 27 at 3:31 PMNexPoint Asset Management Sends Open Letter to the Board of Paratek Pharmaceuticals Regarding Upcoming Annual Meeting and Proposed Acquisition by Gurnet Point Capitalfinance.yahoo.com - June 27 at 10:30 AMEuropean Medicines Agency COMP Recommends Positive Opinion on Orphan Medicinal Product Designation for NUZYRA® (omadacycline) for Treatment of Nontuberculous Mycobacterial (NTM) Lung Diseasefinance.yahoo.com - June 27 at 10:30 AMParatek Pharmaceuticals plans to go private in $462M dealbizjournals.com - June 12 at 5:03 PMParatek Pharmaceuticals Presenting New Data from NUZYRA® (omadacycline) and Investigator-Initiated Research Programs at ASM Microbe 2023finance.yahoo.com - June 12 at 5:03 PMPRTK Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Paratek Pharmaceuticals, Inc. Is Fair to Shareholdersbusinesswire.com - June 11 at 2:14 AMThe Petri Dish: Startup chaired by Vertex founder raises $150M, Paratek to go private in $462M dealbizjournals.com - June 8 at 10:46 AMJefferies Downgrades Paratek Pharmaceuticals (PRTK)msn.com - June 7 at 7:50 PMH.C. Wainwright downgrades Paratek Pharmaceuticals (PRTK) to a Holdmarkets.businessinsider.com - June 7 at 9:48 AMWhy Paratek Pharmaceuticals Stock Is Up Todaybenzinga.com - June 6 at 6:43 PMParatek Pharmaceuticals Agrees To Be Taken Private By Gurnet Point And Novo Holdings For $462Mmsn.com - June 6 at 6:43 PMParatek Pharmaceuticals Shares Rise on Deal to Go Private >PRTKmarketwatch.com - June 6 at 6:43 PMParatek Pharmaceuticals to Be Acquired in Deal Worth Up to $462 Million >PRTKmarketwatch.com - June 6 at 1:43 PMParatek Pharmaceuticals to be taken private in deal worth up to $462Mmsn.com - June 6 at 1:43 PMParatek Pharmaceuticals to be Acquired by Gurnet Point Capital and Novo Holdingsfinance.yahoo.com - June 6 at 1:43 PMmarketbeat.com - June 6 at 8:43 AMParatek Pharamceuticals jumps amid report about takeover interestmsn.com - June 1 at 3:49 PMParatek Pharmaceuticals (NASDAQ:PRTK) investors are sitting on a loss of 83% if they invested five years agofinance.yahoo.com - May 15 at 3:47 PMParatek Pharmaceuticals (NASDAQ:PRTK) Upgraded by StockNews.com to "Buy"marketbeat.com - May 12 at 10:20 PMQ2 2023 Earnings Estimate for Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Issued By HC Wainwrightmarketbeat.com - May 12 at 7:55 AMParatek Pharmaceuticals, Inc. (NASDAQ:PRTK) Q1 2023 Earnings Call Transcriptfinance.yahoo.com - May 10 at 3:43 PMQ1 2023 Paratek Pharmaceuticals Inc Earnings Callfinance.yahoo.com - May 10 at 10:43 AM Get Paratek Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTK and its competitors with MarketBeat's FREE daily newsletter. Email Address Urgent Nvidia Warning (Ad)Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space. Click here to access… PRTK Media Mentions By Week PRTK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRTK News Sentiment▼0.000.43▲Average Medical News Sentiment PRTK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRTK Articles This Week▼01▲PRTK Articles Average Week Get Paratek Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NGM Biopharmaceuticals News Today Kinnate Biopharma News Today Hookipa Pharma News Today Kezar Life Sciences News Today NextCure News Today LianBio News Today Genetron News Today Vor Biopharma News Today Outset Medical News Today FitLife Brands News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRTK) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldUrgent Nvidia WarningAltimetryAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldGold ManiaStansberry ResearchThe Gold Grab of the CenturyColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Paratek Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
